I come to the Senate floor today to talk about something that has been bothering me. Who is this Senate supposed to be working for? For years now, this economy has been great for those at the top, but for everyone else, it is getting harder and harder to make it from paycheck to paycheck, harder and harder to build any real security. The world is changing, and Congress can make decisions that help working people stay in the game and help level the playing field or we can just turn our backs. What have the Republicans done over the past 6 months to try to make families a little more secure, to give people a fighting chance? What have they done? They have turned their backs. In the past 6 months, they have burned huge amounts of time as they tried to shut down Homeland Security, tried to build a pipeline to help a Canadian oil company, tried to turn a human trafficking bill into a referendum on abortion, and now tried to defund Planned Parenthood--all this instead of working on the kinds of issues that would help level the playing field for hard-working people. You know, there is a lot we could do. For example, Democrats have been fighting to raise the minimum wage. And I strongly agree that no one--no one--should work full time and still live in poverty. I think a $7.25-an-hour minimum wage is disgraceful. I support the Federal bill to raise the minimum wage to $12 by 2020, and I applaud the fight for $15 that is springing up across this country.…
Share
More from Elizabeth Warren
We’re in an emergency situation, and we need to be using all the tools we have to make more medicines here at home, and that should include federal contracting and procurement policy.
The federal government unfairly excluded tribal nations from accessing emergency health grants during COVID-19, leaving communities high and dry and breaking our country’s promise to Tribes. We can’t wait for the next public health…
Without greater visibility into these acquisitions, it is not just national security that could be on the line — Americans’ access to medicines is also at risk.
We need more visibility into what’s happening in these transactions when it has the potential to influence such an important part of our pharmaceutical chain.





